RecruitingNCT07704320

Clinical Assessment of the BreathAlert Device in Monitoring Apneic Episodes

Pilot Clinical Assessment of the BreathAlert Device in Monitoring Apneic Episodes in Infants at Risk for Apnea

Sponsor

William Marsh Rice University

Enrollment

60 participants

Start Date

Mar 11, 2017

Study Type

OBSERVATIONAL

Conditions

Apnea Infant

Summary

A team of researchers at Rice University in partnership with clinicians at Queen Elizabeth Central Hospital created BreathAlert, a low cost battery-powered monitor that detects and corrects apnea. This study evaluates the ability of BreathAlert to detect respiration and apneic episodes in infants. Data from BreathAlert and vital signs monitors is collected. The performance of BreathAlert in respiration and apnea detection is compared with traditional vital sign monitoring which may include temperature, heart rate, EKG, respiratory rate, SPO2 and impedance pneumography.

Eligibility

Min Age: 0 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called BreathAlert (low cost respiratory rate and apnea monitor) for people with apnea infant. The study is currently recruiting participants at 1 location. People eligible for this study include aged 0 Years to 17 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBreathAlert (low cost respiratory rate and apnea monitor)

A BreathAlert device is attached to the subject. Data from BreathAlert and vital signs monitors is collected.

Locations(1)

Queen Elizabeth Central Hospital

Blantyre, Malawi

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07704320